Antiplatelet effects of fibrinolytic agents: a potential contributor to the hemostatic defect after thrombolysis.
Kamat
S G
SG
Hematology-Oncology Section, Baylor College of Medicine, Houston, Texas, USA.
Schafer
A I
AI
D001792:Blood Platelets / Q000187:drug effects*; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects; D010980:Platelet Membrane Glycoproteins / Q000502:physiology; D015912:Thrombolytic Therapy
D005343:Fibrinolytic Agents; D010980:Platelet Membrane Glycoproteins